Sign up to save your podcasts
Or
Share Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6262 ratings
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
More shows like Breast Cancer Update
View all
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
13 Listeners
Learn Spanish | SpanishPod101.com
667 Listeners
Gynecologic Oncology Update
13 Listeners
Hematologic Oncology Update
69 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
113 Listeners
Breastcancer.org Podcast
45 Listeners
JAMA Clinical Reviews
489 Listeners
ASCO Daily News
56 Listeners
Investigating Breast Cancer
101 Listeners
ASCO Guidelines
45 Listeners
Oncology Today with Dr Neil Love
60 Listeners
Honestly with Bari Weiss
8,560 Listeners
Two Onc Docs
169 Listeners